{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:33:10Z","timestamp":1768293190189,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_9","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"187-206","source":"Crossref","is-referenced-by-count":9,"title":["Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine"],"prefix":"10.1007","author":[{"given":"Shin","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","volume":"2","author":"BH Bird","year":"2012","unstructured":"Bird BH, Nichol ST (2012) Breaking the chain: Rift Valley fever virus control via livestock vaccination. Curr Opin Virol 2:315\u2013323","journal-title":"Curr Opin Virol"},{"issue":"Pt 10","key":"9_CR2","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","volume":"66","author":"H Caplen","year":"1985","unstructured":"Caplen H, Peters CJ, Bishop DH (1985) Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66(Pt 10):2271\u20132277","journal-title":"J Gen Virol"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","volume":"48","author":"JC Morrill","year":"1987","unstructured":"Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ, Peters CJ (1987) Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48:1042\u20131047","journal-title":"Am J Vet Res"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","volume":"21","author":"HH Balkhy","year":"2003","unstructured":"Balkhy HH, Memish ZA (2003) Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents 21:153\u2013157","journal-title":"Int J Antimicrob Agents"},{"key":"9_CR5","volume-title":"Rift Valley fever virus","author":"CJ Peters","year":"1989","unstructured":"Peters CJ, Meegan JM (1989) Rift Valley fever virus. CRC Press, Boca Raton, FL"},{"key":"9_CR6","first-page":"571","volume-title":"Textbook of human Virology","author":"CJ Peters","year":"1999","unstructured":"Peters CJ, LeDuc JW (1999) Bunyaviruses, phleboviruses, and related viruses. In: Belshe RB (ed) Textbook of human Virology. Mosby Year Book, St.Louis, pp 571\u2013614"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4269\/ajtmh.1988.38.440","volume":"38","author":"TP Gargan","year":"1988","unstructured":"Gargan TP, Clark GG, Dohm DJ, Turell MJ, Bailey CL (1988) Vector potential of selected North American mosquito species for Rift Valley fever virus. Am J Trop Med Hyg 38:440\u2013446","journal-title":"Am J Trop Med Hyg"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0166-3542(02)00203-6","volume":"57","author":"RW Sidwell","year":"2003","unstructured":"Sidwell RW, Smee DF (2003) Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 57:101\u2013111","journal-title":"Antiviral Res"},{"issue":"Suppl 4","key":"9_CR9","doi-asserted-by":"publisher","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","volume":"27","author":"T Ikegami","year":"2009","unstructured":"Ikegami T, Makino S (2009) Rift valley fever vaccines. Vaccine 27(Suppl 4):D69\u2013D72","journal-title":"Vaccine"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","volume":"142","author":"TG Besselaar","year":"1991","unstructured":"Besselaar TG, Blackburn NK, Meenehan GM (1991) Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains. Res Virol 142:469\u2013474","journal-title":"Res Virol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0140-6736(80)91395-1","volume":"1","author":"RE Shope","year":"1980","unstructured":"Shope RE, Peters CJ, Walker JS (1980) Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup. Lancet 1:886\u2013887","journal-title":"Lancet"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4269\/ajtmh.1982.31.149","volume":"31","author":"RB Tesh","year":"1982","unstructured":"Tesh RB, Peters CJ, Meegan JM (1982) Studies on the antigenic relationship among phleboviruses. Am J Trop Med Hyg 31:149\u2013155","journal-title":"Am J Trop Med Hyg"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0042-6822(87)90174-7","volume":"161","author":"GW Anderson","year":"1987","unstructured":"Anderson GW, Smith JF (1987) Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes. Virology 161:91\u2013100","journal-title":"Virology"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01316748","volume":"121","author":"TG Besselaar","year":"1991","unstructured":"Besselaar TG, Blackburn NK (1991) Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch Virol 121:111\u2013124","journal-title":"Arch Virol"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","volume":"41","author":"DG Harrington","year":"1980","unstructured":"Harrington DG, Lupton HW, Crabbs CL, Peters CJ, Reynolds JA, Slone TW Jr (1980) Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep. Am J Vet Res 41:1559\u20131564","journal-title":"Am J Vet Res"},{"key":"9_CR16","first-page":"197","volume":"92","author":"BS Niklasson","year":"1984","unstructured":"Niklasson BS, Meadors GF, Peters CJ (1984) Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters. Acta Pathol Microbiol Immunol Scand C 92:197\u2013200","journal-title":"Acta Pathol Microbiol Immunol Scand C"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","volume":"6","author":"CJ Peters","year":"1986","unstructured":"Peters CJ, Reynolds JA, Slone TW, Jones DE, Stephen EL (1986) Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res 6:285\u2013297","journal-title":"Antiviral Res"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF01311021","volume":"99","author":"CJ Peters","year":"1988","unstructured":"Peters CJ, Jones D, Trotter R, Donaldson J, White J, Stephen E, Slone TW Jr (1988) Experimental Rift Valley fever in rhesus macaques. Arch Virol 99:31\u201344","journal-title":"Arch Virol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","volume":"18","author":"PR Pittman","year":"1999","unstructured":"Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ (1999) Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 18:181\u2013189","journal-title":"Vaccine"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","volume":"170","author":"CS Schmaljohn","year":"1989","unstructured":"Schmaljohn CS, Parker MD, Ennis WH, Dalrymple JM, Collett MS, Suzich JA, Schmaljohn AL (1989) Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology 170:184\u2013192","journal-title":"Virology"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","volume":"24","author":"K Spik","year":"2006","unstructured":"Spik K, Shurtleff A, McElroy AK, Guttieri MC, Hooper JW, SchmalJohn C (2006) Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 24:4657\u20134666","journal-title":"Vaccine"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0034-5288(92)90029-2","volume":"52","author":"A Baskerville","year":"1992","unstructured":"Baskerville A, Hubbard KA, Stephenson JR (1992) Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine. Res Vet Sci 52:307\u2013311","journal-title":"Res Vet Sci"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","volume":"52","author":"KA Hubbard","year":"1991","unstructured":"Hubbard KA, Baskerville A, Stephenson JR (1991) Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever. Am J Vet Res 52:50\u201355","journal-title":"Am J Vet Res"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","volume":"9","author":"JC Morrill","year":"1991","unstructured":"Morrill JC, Carpenter L, Taylor D, Ramsburg HH, Quance J, Peters CJ (1991) Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9:35\u201341","journal-title":"Vaccine"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","volume":"58","author":"JC Morrill","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ (1997) Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58:1110\u20131114","journal-title":"Am J Vet Res"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","volume":"58","author":"JC Morrill","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ (1997) Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58:1104\u20131109","journal-title":"Am J Vet Res"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","volume":"21","author":"JC Morrill","year":"2003","unstructured":"Morrill JC, Peters CJ (2003) Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 21:2994\u20133002","journal-title":"Vaccine"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"e2746","DOI":"10.1371\/journal.pntd.0002746","volume":"8","author":"S Murakami","year":"2014","unstructured":"Murakami S, Terasaki K, Ramirez SI, Morrill JC, Makino S (2014) Development of a novel, single-cycle replicable rift valley fever vaccine. PLoS Negl Trop Dis 8:e2746","journal-title":"PLoS Negl Trop Dis"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","volume":"80","author":"T Ikegami","year":"2006","unstructured":"Ikegami T, Won S, Peters CJ, Makino S (2006) Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80:2933\u20132940","journal-title":"J Virol"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","volume":"73","author":"UJ Buchholz","year":"1999","unstructured":"Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251\u2013259","journal-title":"J Virol"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","volume":"58","author":"K Keegan","year":"1986","unstructured":"Keegan K, Collett MS (1986) Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus. J Virol 58:263\u2013270","journal-title":"J Virol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:59:56Z","timestamp":1748887196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}